{"ticker": {"uuid": "6aef2621-8a2d-4cd8-a942-46b58cb28711", "symbol": "BAFNAPH", "name": "Bafna Pharmaceuticals Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQZmcyaEpZSFdXdmFaaG8yeUxDa2JwNDBOejJVb192NG9MT0dRUk9iTkVLSlJ4amFhZG9WYXZrOHN0NUEyZDQ2YzdIdHV3MThLMWNBcC1TLU1uNjZrcXpDNHB0a29wTUZkWEVFcEpVREJ6bWpBd193QXYwTFRjYjZpMnRheTJ5QnpYSjRaY2ZkYU9fNTltNmpnMWViV2pQQWIwTWhTM1N6emoybDVrY0JQa3p3THdUYlpKTUUtSUdjZU84X3loRHB1T1Vn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T10:52:25+00:00", "published_display": "09 Jul 2026 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals promoters report no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNeHhPd0dYQUdlU2g1dXJXUzRFZzBkS0VQVXl5OUNOZzRSeVo1M0ZBc3RvYWJpOXJqeHZ4RE5kVVRKYjhLVmZLZjZKNmwwSjVGamVvR01QN0E0c2lYRGNESV9XOXFzdVRQeW1NQUZqVlhfQWhKc0hvV21TNEVoejFWb2R3YzdyV1RMVlFLOTVwY3k0X2hGNk1yVkVBamFyV0w3V1N5UDNlZnYwWTk1Y08tTmtIaGdSeHdyM3JhX3JJV3l6QQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals promoter confirms no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcmxWZXFGX3M5bGprQzJod1RBeEl3Ynh4RkFnc0lMQXlGa0J3WHVaMXgtYWJReWt5V1hjdW1zN3lVSlcwOVYzb1pnTmozRjdvRTIxa3dFUy0ySHlmdnUwRE1WVWJ5Vmg2bm44d2cwNGpEUkpkLWw1eTlmYzhDRTZ6eVhoS0FLV0NSLW01ZEVHdm9FZ0lOaFJ2QmhBTndHalZyZEJiSlRRVV9MempSeThUOGNheF9BcUdIMy1yRkw0OVZlMm8?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals board to consider FY26 results on May 29", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSUs3MkE4Wk5OMlA2QnJoNWlEeHd1WXFLNlFVTmJvSXl4ZWpLbmlYM1ZHVk4tNWY2d3F2RjZCUlJKeWtvaWY5QlBuVmp4b0ctN3dnMnlUd19NNUNCaUN3YU11NEVIVHNoa2JLQXlpVjNJY1N2U0thTWZVcUtfSnlPM1k3dnVFbWpJdHk2N0JkVE53RXZpMUxwMVBiSTBPVmwwaDZmb2VySDl4dG9kUExkNlNPLVl1Vm9WOEtn?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals Clarifies Share Price Movement Following Stock Exchange Queries", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNSXFaVjh2QkdiT2FtSl9tSmFDcFV1VXphblpsUVI5WlRvNDJkeEdnMHdvcHA0RGROOEtmb1p6cVRCMWpjaUpLZmw4NG54TzR6SjBTd296NWJ2bmhoZC1qZFpoazAzWHpKMzktU3cxWmM1azBzU1hLcWpYRFdtUmFDV0VrVVJwOWZxLXF4TndOUmc2alE2SUlLd1Nack1mWl9ON2FrOW1BSE41WmY5S0dIS3JTbi10cEtZeHctMDVQa2wxT3JuQmhZWjhXX2xSbkpnTGJuQ25XVEoydw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals Ltd. Share Price Today - Bafna Pharmaceuticals Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOTUJpdW1RemNuWmJSWXRQTGdFRVRRT3ZJLUgyM2locmx2NWNXMHpnYmNzWHY1Yl84Qm1kUXV3dWRYMFdCOWU0bE1Od2ExSHZldk9HOGRHRXlvTzU5SC1Hc0xnZnBHTi1LZjVuMGNBWXhOOW8zNWozclpKcWkya3Y5d18zZG91YThRV1E?oc=5", "source_name": "CNBC TV18", "published_at": "2025-09-18T05:35:45+00:00", "published_display": "18 Sep 2025 05:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "In Talks With Multinational Pharma Cos For Acquisition Of Brands: Bafna Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxObTBWaHBrQXZzNHlicENKbmw0bGh2Q1RhSnFfdUVYN2U4aVZPNWFMYTZiWkxvMTNJRl90Vmh5NnM4anlwTjhLTUVlQVlIUUpDZ1NxZm1jdkhKY1o4eUlCeERuQ1lobzI4Z1AwNEh1U2RSUmxkMFVsTm8xM3VRYThfbUpBcFlwRmMzVUNjVXRHOXU1S0VldWJkTS1ZQzR5ZVFVWkZoLU93QWExYURsWlRyZjFwSmpqSUhoTDFIcWJjMUtwNkk1TkF6SWtOMGs1ZEVT?oc=5", "source_name": "BW Healthcare", "published_at": "2025-02-11T08:02:27+00:00", "published_display": "11 Feb 2025 08:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals standalone net profit rises 75.88% in the December 2022 quarter", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2023-02-10T08:00:00+00:00", "published_display": "10 Feb 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mylan, two Indian companies line up to buy Bafna Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQUWFZNUllRzVYU2pnSlpUOXN5VFhSY25VTHJreXNsMVNzdVltYXpqR2tEVHB2VmRpSmdUc3BtUDYzbmZaSlZNMTJBaHI0OHlsYXZDZ2dzNXhEZGdhZFpjZzdpTnhnb3pfWkdRblZkUkh5SFZpWjRRWXk5VXJ1TUN6ak1LekNoVmMzelF0MlR3OU9Vbks5SmE1dFdFWkd4MmM3dUwycmtqMDQ0bVBsZjFDT1hWSk5Mcy13ZDctQVZmQkRaSjdKajI5TlNNY1E5RDV6SGNPMkw1aVV1T0dOX1pmejg2a3lVU29hd3BONjM3NU12QQ?oc=5", "source_name": "The Economic Times", "published_at": "2013-11-26T08:00:00+00:00", "published_display": "26 Nov 2013 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQZmcyaEpZSFdXdmFaaG8yeUxDa2JwNDBOejJVb192NG9MT0dRUk9iTkVLSlJ4amFhZG9WYXZrOHN0NUEyZDQ2YzdIdHV3MThLMWNBcC1TLU1uNjZrcXpDNHB0a29wTUZkWEVFcEpVREJ6bWpBd193QXYwTFRjYjZpMnRheTJ5QnpYSjRaY2ZkYU9fNTltNmpnMWViV2pQQWIwTWhTM1N6emoybDVrY0JQa3p3THdUYlpKTUUtSUdjZU84X3loRHB1T1Vn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-09T10:52:25+00:00", "published_display": "09 Jul 2026 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals promoters report no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNeHhPd0dYQUdlU2g1dXJXUzRFZzBkS0VQVXl5OUNOZzRSeVo1M0ZBc3RvYWJpOXJqeHZ4RE5kVVRKYjhLVmZLZjZKNmwwSjVGamVvR01QN0E0c2lYRGNESV9XOXFzdVRQeW1NQUZqVlhfQWhKc0hvV21TNEVoejFWb2R3YzdyV1RMVlFLOTVwY3k0X2hGNk1yVkVBamFyV0w3V1N5UDNlZnYwWTk1Y08tTmtIaGdSeHdyM3JhX3JJV3l6QQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals promoter confirms no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcmxWZXFGX3M5bGprQzJod1RBeEl3Ynh4RkFnc0lMQXlGa0J3WHVaMXgtYWJReWt5V1hjdW1zN3lVSlcwOVYzb1pnTmozRjdvRTIxa3dFUy0ySHlmdnUwRE1WVWJ5Vmg2bm44d2cwNGpEUkpkLWw1eTlmYzhDRTZ6eVhoS0FLV0NSLW01ZEVHdm9FZ0lOaFJ2QmhBTndHalZyZEJiSlRRVV9MempSeThUOGNheF9BcUdIMy1yRkw0OVZlMm8?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals board to consider FY26 results on May 29", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSUs3MkE4Wk5OMlA2QnJoNWlEeHd1WXFLNlFVTmJvSXl4ZWpLbmlYM1ZHVk4tNWY2d3F2RjZCUlJKeWtvaWY5QlBuVmp4b0ctN3dnMnlUd19NNUNCaUN3YU11NEVIVHNoa2JLQXlpVjNJY1N2U0thTWZVcUtfSnlPM1k3dnVFbWpJdHk2N0JkVE53RXZpMUxwMVBiSTBPVmwwaDZmb2VySDl4dG9kUExkNlNPLVl1Vm9WOEtn?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals Clarifies Share Price Movement Following Stock Exchange Queries", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNSXFaVjh2QkdiT2FtSl9tSmFDcFV1VXphblpsUVI5WlRvNDJkeEdnMHdvcHA0RGROOEtmb1p6cVRCMWpjaUpLZmw4NG54TzR6SjBTd296NWJ2bmhoZC1qZFpoazAzWHpKMzktU3cxWmM1azBzU1hLcWpYRFdtUmFDV0VrVVJwOWZxLXF4TndOUmc2alE2SUlLd1Nack1mWl9ON2FrOW1BSE41WmY5S0dIS3JTbi10cEtZeHctMDVQa2wxT3JuQmhZWjhXX2xSbkpnTGJuQ25XVEoydw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals Ltd. Share Price Today - Bafna Pharmaceuticals Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOTUJpdW1RemNuWmJSWXRQTGdFRVRRT3ZJLUgyM2locmx2NWNXMHpnYmNzWHY1Yl84Qm1kUXV3dWRYMFdCOWU0bE1Od2ExSHZldk9HOGRHRXlvTzU5SC1Hc0xnZnBHTi1LZjVuMGNBWXhOOW8zNWozclpKcWkya3Y5d18zZG91YThRV1E?oc=5", "source_name": "CNBC TV18", "published_at": "2025-09-18T05:35:45+00:00", "published_display": "18 Sep 2025 05:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "In Talks With Multinational Pharma Cos For Acquisition Of Brands: Bafna Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxObTBWaHBrQXZzNHlicENKbmw0bGh2Q1RhSnFfdUVYN2U4aVZPNWFMYTZiWkxvMTNJRl90Vmh5NnM4anlwTjhLTUVlQVlIUUpDZ1NxZm1jdkhKY1o4eUlCeERuQ1lobzI4Z1AwNEh1U2RSUmxkMFVsTm8xM3VRYThfbUpBcFlwRmMzVUNjVXRHOXU1S0VldWJkTS1ZQzR5ZVFVWkZoLU93QWExYURsWlRyZjFwSmpqSUhoTDFIcWJjMUtwNkk1TkF6SWtOMGs1ZEVT?oc=5", "source_name": "BW Healthcare", "published_at": "2025-02-11T08:02:27+00:00", "published_display": "11 Feb 2025 08:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bafna Pharmaceuticals standalone net profit rises 75.88% in the December 2022 quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPdmNpeHdqbkpnRUxxU1V4Rm5XaXlOdHllVnBnZEFtUXVYMW9TWEFhYUZmTlozVFpyV2o2dkl1YUpnMG5TU1NSNnlCbnVwMVAydmdlNUxZMjJHZnJ1bFhzSUNYTXVOQUtQWjhhUmRmcXYzaGsxVHlzR3U0ZGp4aUt5bXJYc05XSWlRZlN1S3pIVlR5SmdjTWNYS2xWX3FMeGJIYTFUdlpKODZGdThoZ2pGX2FiNDN3c3RpRWgwdnFmTGl0NVBNZktoN3ZQRHV2LXVwMFVkWFQzLUktMm5ZVmhrTkhoTEVCX2ZOUHfSAe8BQVVfeXFMT0lpaXNuQ2hOa28zWnV1Z0ZscVFPYS1HVWNRMU1rWXJUNHJucm9obm15MUdLRGVhOEp6bE15Z1NmY3dLenRtQXAycXdERXhybjJCT2JQcHlrVmtyTTJFZmJ2bW8yM3ZaNHFRbHVQWEhUdXB1UzRoSmNoMlJKX0RFUl9fRGk0TlFDejlsZ0RzbU9FUTRjWUowbFpYY3dLcjRtZmx6VktFODRoMWEwVlpmNmh4a2ZOWDFOeWkyaU1ac1FaZlpPQjZoVGo5Ui1OT2RFTGdJc19UMXR5QUJyY1dMd3oxLXhGMElHbF9Oa3JfTFE?oc=5", "source_name": "Business Standard", "published_at": "2023-02-10T08:00:00+00:00", "published_display": "10 Feb 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mylan, two Indian companies line up to buy Bafna Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQUWFZNUllRzVYU2pnSlpUOXN5VFhSY25VTHJreXNsMVNzdVltYXpqR2tEVHB2VmRpSmdUc3BtUDYzbmZaSlZNMTJBaHI0OHlsYXZDZ2dzNXhEZGdhZFpjZzdpTnhnb3pfWkdRblZkUkh5SFZpWjRRWXk5VXJ1TUN6ak1LekNoVmMzelF0MlR3OU9Vbks5SmE1dFdFWkd4MmM3dUwycmtqMDQ0bVBsZjFDT1hWSk5Mcy13ZDctQVZmQkRaSjdKajI5TlNNY1E5RDV6SGNPMkw1aVV1T0dOX1pmejg2a3lVU29hd3BONjM3NU12QQ?oc=5", "source_name": "The Economic Times", "published_at": "2013-11-26T08:00:00+00:00", "published_display": "26 Nov 2013 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 56, "total_relevant": 10, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 8, "score": 54, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 3.45, "count": 5}, {"event": "earnings", "label": "Earnings", "weight": 2.0, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 204.61, "latest_week": "2026-07-10", "one_week_move": -5.5, "four_week_move": 23.7, "twelve_week_move": 46.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.354575, "market_dynamics_buy_signal": false, "relative_strength": 53.575356, "fair_value_gap": 99.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 36.6322, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.5% over one week, +23.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 4}, {"label": "TipRanks", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "CNBC TV18", "count": 1}, {"label": "BW Healthcare", "count": 1}, {"label": "Business Standard", "count": 1}, {"label": "The Economic Times", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Earnings", "count": 3}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-5.5% over one week, +23.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter"}], "updated_at": "2026-07-17T09:59:07.965661+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}